{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Cyclobenzaprine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cyclobenzaprine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cyclobenzaprine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "cyclobenzaprine",
    "trial_2_text": "Cyclobenzaprine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Cyclobenzaprine Supplement: 60 participants will take Cyclobenzaprine 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cyclobenzaprine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cyclobenzaprine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "9": 0.25301694869995117,
      "17": 0.16164256632328033,
      "77": 0.15307210385799408,
      "87": 0.12878447771072388,
      "78": 0.1047399640083313,
      "68": 0.10367581993341446,
      "79": 0.08607997000217438,
      "49": 0.08492913097143173,
      "300": 0.08045589178800583,
      "21": 0.07797865569591522,
      "173": 0.07631970196962357,
      "46": 0.07502897828817368,
      "66": 0.07275976985692978,
      "20": 0.06735295057296753,
      "101": 0.0647001639008522,
      "177": 0.06106759235262871,
      "67": 0.058033496141433716,
      "228": 0.055251967161893845,
      "123": 0.055139344185590744,
      "37": 0.0544617660343647,
      "86": 0.052839670330286026,
      "239": 0.05090552195906639,
      "151": 0.0493660606443882,
      "102": 0.04908185079693794,
      "64": 0.04890843480825424,
      "126": 0.048713319003582,
      "36": 0.044764965772628784,
      "200": 0.04342474788427353,
      "243": 0.04274626076221466,
      "132": 0.041979026049375534,
      "104": 0.04171939194202423,
      "85": 0.040352463722229004,
      "242": 0.03789253905415535,
      "189": 0.03723689913749695,
      "114": 0.03687872737646103,
      "180": 0.03656193986535072,
      "188": 0.03618166595697403,
      "18": 0.03605217859148979,
      "116": 0.034658174961805344,
      "466": 0.03305535390973091,
      "14": 0.03208841755986214,
      "76": 0.03203175589442253,
      "29": 0.03141376003623009,
      "286": 0.03140391781926155,
      "89": 0.030936220660805702,
      "131": 0.030605334788560867,
      "396": 0.030250228941440582,
      "30": 0.029892798513174057,
      "5": 0.029366351664066315,
      "38": 0.02928299456834793,
      "262": 0.029205482453107834,
      "211": 0.028757870197296143,
      "69": 0.028672821819782257,
      "61": 0.028319289907813072,
      "193": 0.026959698647260666,
      "96": 0.0268692746758461,
      "221": 0.026751434430480003,
      "139": 0.026187976822257042,
      "234": 0.026022249832749367,
      "350": 0.025710953399538994,
      "82": 0.025212500244379044,
      "361": 0.024875115603208542,
      "72": 0.024828143417835236,
      "15": 0.024677064269781113,
      "166": 0.02451181411743164,
      "261": 0.02396976575255394,
      "345": 0.023387938737869263,
      "199": 0.023256001994013786,
      "218": 0.023210028186440468,
      "422": 0.022955693304538727,
      "441": 0.022743184119462967,
      "122": 0.022669093683362007,
      "28": 0.02232903242111206,
      "456": 0.022127749398350716,
      "22": 0.021967269480228424,
      "235": 0.021837232634425163,
      "2": 0.021703781560063362,
      "204": 0.02157771587371826,
      "118": 0.02109508030116558,
      "75": 0.020991133525967598,
      "92": 0.02057107910513878,
      "11": 0.020513124763965607,
      "371": 0.020438475534319878,
      "147": 0.02035222016274929,
      "256": 0.01950101926922798,
      "94": 0.019307084381580353,
      "191": 0.01914016529917717,
      "203": 0.019096877425909042,
      "508": 0.018951434642076492,
      "35": 0.018829917535185814,
      "153": 0.018739769235253334,
      "138": 0.01856321096420288,
      "269": 0.018360896036028862,
      "27": 0.018168440088629723,
      "136": 0.017865080386400223,
      "98": 0.017851397395133972,
      "232": 0.017794344574213028,
      "152": 0.01778869517147541,
      "202": 0.017780281603336334,
      "130": 0.01768781617283821
    },
    "trial_2_ae": {
      "9": 0.25301694869995117,
      "17": 0.16164256632328033,
      "77": 0.15307210385799408,
      "87": 0.12878447771072388,
      "78": 0.1047399640083313,
      "68": 0.10367581993341446,
      "79": 0.08607997000217438,
      "49": 0.08492913097143173,
      "300": 0.08045589178800583,
      "21": 0.07797865569591522,
      "173": 0.07631970196962357,
      "46": 0.07502897828817368,
      "66": 0.07275976985692978,
      "20": 0.06735295057296753,
      "101": 0.0647001639008522,
      "177": 0.06106759235262871,
      "67": 0.058033496141433716,
      "228": 0.055251967161893845,
      "123": 0.055139344185590744,
      "37": 0.0544617660343647,
      "86": 0.052839670330286026,
      "239": 0.05090552195906639,
      "151": 0.0493660606443882,
      "102": 0.04908185079693794,
      "64": 0.04890843480825424,
      "126": 0.048713319003582,
      "36": 0.044764965772628784,
      "200": 0.04342474788427353,
      "243": 0.04274626076221466,
      "132": 0.041979026049375534,
      "104": 0.04171939194202423,
      "85": 0.040352463722229004,
      "242": 0.03789253905415535,
      "189": 0.03723689913749695,
      "114": 0.03687872737646103,
      "180": 0.03656193986535072,
      "188": 0.03618166595697403,
      "18": 0.03605217859148979,
      "116": 0.034658174961805344,
      "466": 0.03305535390973091,
      "14": 0.03208841755986214,
      "76": 0.03203175589442253,
      "29": 0.03141376003623009,
      "286": 0.03140391781926155,
      "89": 0.030936220660805702,
      "131": 0.030605334788560867,
      "396": 0.030250228941440582,
      "30": 0.029892798513174057,
      "5": 0.029366351664066315,
      "38": 0.02928299456834793,
      "262": 0.029205482453107834,
      "211": 0.028757870197296143,
      "69": 0.028672821819782257,
      "61": 0.028319289907813072,
      "193": 0.026959698647260666,
      "96": 0.0268692746758461,
      "221": 0.026751434430480003,
      "139": 0.026187976822257042,
      "234": 0.026022249832749367,
      "350": 0.025710953399538994,
      "82": 0.025212500244379044,
      "361": 0.024875115603208542,
      "72": 0.024828143417835236,
      "15": 0.024677064269781113,
      "166": 0.02451181411743164,
      "261": 0.02396976575255394,
      "345": 0.023387938737869263,
      "199": 0.023256001994013786,
      "218": 0.023210028186440468,
      "422": 0.022955693304538727,
      "441": 0.022743184119462967,
      "122": 0.022669093683362007,
      "28": 0.02232903242111206,
      "456": 0.022127749398350716,
      "22": 0.021967269480228424,
      "235": 0.021837232634425163,
      "2": 0.021703781560063362,
      "204": 0.02157771587371826,
      "118": 0.02109508030116558,
      "75": 0.020991133525967598,
      "92": 0.02057107910513878,
      "11": 0.020513124763965607,
      "371": 0.020438475534319878,
      "147": 0.02035222016274929,
      "256": 0.01950101926922798,
      "94": 0.019307084381580353,
      "191": 0.01914016529917717,
      "203": 0.019096877425909042,
      "508": 0.018951434642076492,
      "35": 0.018829917535185814,
      "153": 0.018739769235253334,
      "138": 0.01856321096420288,
      "269": 0.018360896036028862,
      "27": 0.018168440088629723,
      "136": 0.017865080386400223,
      "98": 0.017851397395133972,
      "232": 0.017794344574213028,
      "152": 0.01778869517147541,
      "202": 0.017780281603336334,
      "130": 0.01768781617283821
    }
  },
  "safety": {
    "trial_1_safety": 0.2654098868370056,
    "trial_2_safety": 0.2654098868370056
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4783487021923065
  }
}